New diabetes clinical trial: Semaglutide for Smoking Cessation in Patients With Diabetes

Published on: July 09, 2025 at 11:00PM
Conditions: Diabetes Mellitus, Type 2; Nicotine Addiction; Tobacco Dependence
Interventions: Drug: Semaglutide; Drug: Nicotine replacement
Sponsors: Ottawa Heart Institute Research Corporation
Not yet recruiting
https://ift.tt/ENFlohu